699 related articles for article (PubMed ID: 10385124)
1. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta.
Masutani C; Kusumoto R; Yamada A; Dohmae N; Yokoi M; Yuasa M; Araki M; Iwai S; Takio K; Hanaoka F
Nature; 1999 Jun; 399(6737):700-4. PubMed ID: 10385124
[TBL] [Abstract][Full Text] [Related]
2. Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by human and mouse DNA polymerase eta.
Yamada A; Masutani C; Iwai S; Hanaoka F
Nucleic Acids Res; 2000 Jul; 28(13):2473-80. PubMed ID: 10871396
[TBL] [Abstract][Full Text] [Related]
3. Replication of damaged DNA: molecular defect in xeroderma pigmentosum variant cells.
Cordonnier AM; Fuchs RP
Mutat Res; 1999 Oct; 435(2):111-9. PubMed ID: 10556591
[TBL] [Abstract][Full Text] [Related]
4. hRAD30 mutations in the variant form of xeroderma pigmentosum.
Johnson RE; Kondratick CM; Prakash S; Prakash L
Science; 1999 Jul; 285(5425):263-5. PubMed ID: 10398605
[TBL] [Abstract][Full Text] [Related]
5. Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations.
Wang Y; Woodgate R; McManus TP; Mead S; McCormick JJ; Maher VM
Cancer Res; 2007 Apr; 67(7):3018-26. PubMed ID: 17409408
[TBL] [Abstract][Full Text] [Related]
6. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
Cleaver JE
J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
[TBL] [Abstract][Full Text] [Related]
7. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity.
Masutani C; Araki M; Yamada A; Kusumoto R; Nogimori T; Maekawa T; Iwai S; Hanaoka F
EMBO J; 1999 Jun; 18(12):3491-501. PubMed ID: 10369688
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of Xeroderma pigmentosum variant.
Gratchev A; Strein P; Utikal J; Sergij G
Exp Dermatol; 2003 Oct; 12(5):529-36. PubMed ID: 14705792
[TBL] [Abstract][Full Text] [Related]
9. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene.
Yuasa M; Masutani C; Eki T; Hanaoka F
Oncogene; 2000 Sep; 19(41):4721-8. PubMed ID: 11032022
[TBL] [Abstract][Full Text] [Related]
10. Abnormal, error-prone bypass of photoproducts by xeroderma pigmentosum variant cell extracts results in extreme strand bias for the kinds of mutations induced by UV light.
McGregor WG; Wei D; Maher VM; McCormick JJ
Mol Cell Biol; 1999 Jan; 19(1):147-54. PubMed ID: 9858539
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
12. Fidelity of human DNA polymerase eta.
Johnson RE; Washington MT; Prakash S; Prakash L
J Biol Chem; 2000 Mar; 275(11):7447-50. PubMed ID: 10713043
[TBL] [Abstract][Full Text] [Related]
13. Polymerase eta deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair.
Limoli CL; Giedzinski E; Morgan WF; Cleaver JE
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7939-46. PubMed ID: 10859352
[TBL] [Abstract][Full Text] [Related]
14. Translesion replication in cisplatin-treated xeroderma pigmentosum variant cells is also caffeine-sensitive: features of the error-prone DNA polymerase(s) involved in UV-mutagenesis.
Yamada K; Takezawa J; Ezaki O
DNA Repair (Amst); 2003 Aug; 2(8):909-24. PubMed ID: 12893087
[TBL] [Abstract][Full Text] [Related]
15. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
[TBL] [Abstract][Full Text] [Related]
16. The RAD30 cancer susceptibility gene.
Carty MP; Glynn M; Maher M; Smith T; Yao J; Dixon K; McCann J; Rynn L; Flanagan A
Biochem Soc Trans; 2003 Feb; 31(Pt 1):252-6. PubMed ID: 12546696
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.
Broughton BC; Cordonnier A; Kleijer WJ; Jaspers NG; Fawcett H; Raams A; Garritsen VH; Stary A; Avril MF; Boudsocq F; Masutani C; Hanaoka F; Fuchs RP; Sarasin A; Lehmann AR
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):815-20. PubMed ID: 11773631
[TBL] [Abstract][Full Text] [Related]
18. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells.
Kannouche P; Broughton BC; Volker M; Hanaoka F; Mullenders LH; Lehmann AR
Genes Dev; 2001 Jan; 15(2):158-72. PubMed ID: 11157773
[TBL] [Abstract][Full Text] [Related]
19. Defective bypass replication of a leading strand cyclobutane thymine dimer in xeroderma pigmentosum variant cell extracts.
Svoboda DL; Briley LP; Vos JM
Cancer Res; 1998 Jun; 58(11):2445-8. PubMed ID: 9622087
[TBL] [Abstract][Full Text] [Related]
20. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
Martens MC; Emmert S; Boeckmann L
Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
